Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) EBT Margin (2020 - 2026)

RxSight filings provide 6 years of EBT Margin readings, the most recent being 28.05% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 8147.0% to 28.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 28.91%, a 2891.0% decrease, with the full-year FY2025 number at 28.91%, down 2891.0% from a year prior.
  • EBT Margin hit 28.05% in Q4 2025 for RxSight, up from 32.32% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 391.19% in Q4 2021 to a low of 275.15% in Q2 2021.
  • Median EBT Margin over the past 5 years was 45.41% (2023), compared with a mean of 61.59%.
  • The widest YoY moves for EBT Margin: up 67041bps in 2021, down -95464bps in 2021.
  • RxSight's EBT Margin stood at 391.19% in 2021, then tumbled by -125bps to 97.0% in 2022, then surged by 67bps to 32.18% in 2023, then surged by 266bps to 53.41% in 2024, then plummeted by -153bps to 28.05% in 2025.
  • The last three reported values for EBT Margin were 28.05% (Q4 2025), 32.32% (Q3 2025), and 34.94% (Q2 2025) per Business Quant data.